Aug 01, 2024 Join a group of passionate international experts to learn about innovative biomaterials, the changing regulatory landscape, and what we can learn from failed 3D-printed implants. Please register now to be part of this inspiring conversation that promises to reshape how we think about orthopedic care.
Apply to speak or sponsor the event: info@3dheals.com
Subscribe here to receive event emails.
Speakers:
Esther Valliant
Esther Valliant’s research over the last fifteen years has focused principally on biomaterials for hard tissue applications and the development of new medical devices. Highlights include improving the mechanical properties of bioactive glass by forming a flexible hybrid, developing an osteoconductive PMMA-free orthopedic cement for spinal surgery. She has authored of over 16 peer-reviewed journal articles, an inventor of a patent for an internal medical device and a reviewer for two scientific journals. She earned her undergraduate degree in Chemical Engineering from Queen’s University (Kingston, Canada), her PhD in Material Science from Imperial College London (London, UK), and completed a post-doctoral fellowship in Biomedical Engineering at Dalhousie University (Halifax, Canada).
Bryan Scheer
Bryan Scheer, M.D. is a Board Certified Orthopedic Surgeon. Dr.Scheer received his medical degree at the University of Nevada and completed his orthopedics residency at the University of Oklahoma. After more than ten years of practice in rural hospitals, he co-founded inReach Healthcare (fka Rural Partners in Medicine -RPM). InReach’s mission has always been to empower rural hospitals and give them an avenue to provide specialty medical care to their patients. This also opened the door to give some balance to the maldistribution of specialty providers in these small, remote, underserved communities. InReach contracts directly with individual hospitals to keep patients and revenue local. This has positively impacted the physical health and economic viability for these partnering hospitals. Quickly, the demand became larger than what he could individually supply, so he recruited fellow orthopedic surgeons and expanded their scope. InReach has six separate divisions and offers numerous services/specialties in 18 states and over 100 hospitals. Striving to further enhance patient outcomes, Dr. Scheer developed a strong interest in alternative materials and applications for medical use which led to the founding of SiNAPTIC Technologies. SiNAPTIC focuses on Additive Manufacturing of complex and technical ceramics. 3-D printed biomaterials are the cutting edge in performance and improved outcomes but also further improve daily lives through the many uses in industry, electronics, and aerospace/defense. Both inReach and SiNAPTIC are based north of Denver, CO. Dr. Scheer lives full time in Steamboat Springs, CO with his wife Melanie. They share four adult children.
Jennifer Palinchik
Jennifer Palinchik is President and Co-Founder of JALEX Medical, LLC. The company is located just outside of Cleveland, OH and provides Medical Device Design, Regulatory, and Quality Consultation services to companies, hospitals, and surgeon inventors seeking entrance into the Medical Device Market. She brings over 20 years of experience in the field, specializing in design and development and regulatory affairs activities. Under her leadership, the company has experienced year over year growth and has achieved a significant amount of device clearances thru the Food and Drug Administration (FDA). Earlier in her career, she performed artificial pancreas and kidney stem cell research for animal studies and clinical trials. She is an active member in regional organizations that promote biomedical and healthcare in Northeast Ohio, has been a guest speaker at conferences for the medical industry, sits on several advisory boards, and has been featured in several local and national publications. She holds a Bachelor of Science in Biomedical Engineering degree from the University of Toledo and a Master in Business Administration in Executive Management & Entrepreneurship degree from Ashland University.
Harry Hothi
I have 15 years’ experience in implant research, development, and regulation. My background is in mechanical (BEng) and orthopaedic (MSc, PhD) engineering. I have extensive experience of working closely with spine, hip and knee surgeons, hospital R&D teams within the NHS and Europe, healthcare regulators, notified bodies, academic researchers, engineers, scientists, and orthopaedic manufacturers.
I have published 86 peer-reviewed journal papers with over 110 co-authors on research relating to the analysis of new and retrieved orthopaedic implants (post-market surveillance). This has led to more than 150 abstracts accepted for podium presentation at international conferences in Europe and the US.
My key research themes have included the analysis of metal-on-metal hip implants, dual-taper stem hips, knee implants and medical imaging, magnetically controlled growing spine rods and lower-limb nails, additive-manufactured implants, and the use of blood metal ion testing to monitor the function of implants.
Moderator:
Craig Rosenblum
Craig Rosenblum is the President of Himed. Over 30 years of operation, Himed has become a global leader in calcium phosphate-based biomaterial production and has developed proprietary plasma spray coatings and surface treatments. Craig and his team collaborate directly with dental and medical device manufacturers around the world to provide innovative biomaterial solutions. Craig discovered a unique application for MATRIX MCD® post-processing additively manufactured titanium implantable devices using Himed’s proprietary and biocompatible resorbable blast media
Now on Demand:
Thanks to our sponsor:
Comments